Background pattern

REGKIRONA 60 mg/mL concentrate for infusion solution

Ask a doctor about a prescription for REGKIRONA 60 mg/mL concentrate for infusion solution

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use REGKIRONA 60 mg/mL concentrate for infusion solution

Introduction

Patient Information: Summary of Product Characteristics

Regkirona 60 mg/ml concentrate for solution for infusion

regdanvimab

This medicinal product is subject to additional monitoring, which will allow for the quick identification of new safety information. You can help by reporting any side effects you may get. The last section of this leaflet includes information on how to report side effects.

Read all of this leaflet carefully before you start receiving this medicine, because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or nurse.
  • If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Regkirona and what is it used for
  1. What you need to know before you are given Regkirona
  2. How Regkirona is given
  3. Possible side effects
  4. Storage of Regkirona
  5. Contents of the pack and other information

1. What is Regkirona and what is it used for

The active substance of Regkirona is regdanvimab, which is a monoclonal antibody used for the treatment of COVID-19, a disease caused by a virus called SARS-CoV-2.

Regkirona is given to adult patients with COVID-19 who do not require supplemental oxygen and are at high risk of severe COVID-19 worsening.

This medicine prevents the virus from entering human cells by binding to the spike protein of SARS-CoV-2. When it binds to the spike protein, it blocks the interaction between the virus and the cell receptor, and this reduces the virus's ability to enter the body's cells. In this way, it helps the body to resist the infection and may help prevent the disease from worsening.

2. What you need to know before you are given Regkirona

You must not be given Regkirona

  • if you are allergic to regdanvimab or any of the other ingredients of this medicine

(listed in section 6).

  • Tell your doctor or nurse as soon as possible if this applies to you.

Warnings and precautions

Reactions after receiving the medicine

This medicine may cause allergic reactions or other reactions after it is given. See also section 4, "Possible side effects". The symptoms may include:

  • Fever
  • Difficulty breathing
  • Shortness of breath, rapid breathing or rapid heartbeat
  • Chills
  • Fatigue
  • Irregular, rapid or slow heartbeat
  • Chest pain or discomfort
  • Weakness
  • Confusion
  • Feeling sick (nausea)
  • Headache
  • Shortness of breath, wheezing
  • Low or high blood pressure
  • Swelling of the face, lips or throat (angioedema)
  • Rash, including hives
  • Itching
  • Muscle pain
  • Feeling dizzy
  • Dizziness
  • Sweating
  • Seek medical attention immediatelyif you experience any of these symptoms.

Children and adolescents

This medicine must not be given to children and adolescents under 18 years of age, as there are no data to indicate that this medicine is safe and effective in this age group.

Other medicines and Regkirona

Tell your doctor or nurseif you are taking or have recently taken any other medicines.

It is not known if this medicine affects other medicines or if they may have an effect on it. Your healthcare team will monitor you for possible signs of drug interactions.

Pregnancy and breastfeeding

If you are pregnant, think you may be pregnantor plan to become pregnant, consult your doctorbefore receiving Regkirona. Your doctor will advise you if the benefits of treatment with Regkirona outweigh the potential risks to you and your baby.

It is not known if the components of Regkirona are excreted in breast milk. If you are breastfeeding, consult your doctorbefore receiving Regkirona.

Driving and using machines

Regkirona is not expected to have any effect on the ability to drive or use tools or machines.

3. How Regkirona is given

A doctor or nurse will give you this medicine by infusion into a vein (intravenous infusion) over 60 minutes.

The recommended dose is a single dose of 40 mg/kg. This medicine should be given within 7 days of the onset of symptoms.

This medicine may cause infusion reactions after it is given. You will be closely monitored during treatment and for at least 1 hour after the end of the infusion.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor or nurse if you experience any of the following side effects:

  • Uncommon:may affect up to 1 in 100 people
  • Infusion reactions (e.g. fever; difficulty breathing;

slow, rapid or irregular heartbeat, high blood pressure; rash, including hives; itching or feeling faint)

These types of reactions usually occur within a few minutes to several hours after the infusion is completed.

Reporting of side effects

If you experience any side effects, talk to your doctor or nurse, even if they are not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Regkirona

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month shown.

Store in a refrigerator (between 2 °C and 8 °C). Keep the container in the outer carton to protect it from light. Do not freeze.

Do not use this medicine if you notice particles or color changes before administration.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Container Content and Additional Information

Composition of Regkirona

  • The active substance is regdanvimab. The vial contains 960 mg of regdanvimab in 16 ml (60 mg/ml).
  • The other components are L-histidine, L-histidine monohydrochloride monohydrate, polysorbate 80, L-arginine hydrochloride, and water for injectable preparations.

Appearance of the Product and Container Content

This medicine is a transparent to opalescent solution, colorless to pale yellow. It is presented in a glass vial with a rubber stopper and sealed with an aluminum flip-off cap containing concentrate for solution for infusion.

Regkirona is available in packs of 1 vial.

Marketing Authorization Holder

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Manufacturers

NUVISAN GmbH

Wegenerstr. 13,

Neu-Ulm, Bayern, 89231

GERMANY

NUVISAN FRANCE SARL

2400 route des Colles,

06410 BIOT,

FRANCE

You can request more information about this medicine by contacting the local representative of the marketing authorization holder:

Belgium

Celltrion Healthcare Belgium BVBA

Tel: +32 1528 7418

[email protected]

Lithuania

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B

tower

Hungary

Tel: +36 1 231 0493

[email protected]

Bulgaria

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Bulgaria

Tel: +36 1 231 0493

[email protected]

Luxembourg

Celltrion Healthcare Belgium BVBA

Tel: +32 1528 7418

[email protected]

Czech Republic

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

Hungary

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

Denmark

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

Malta

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

Germany

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

Netherlands

Celltrion Healthcare Netherlands B.V.

Tel: +31 20 888 7300

[email protected]

Estonia

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

Norway

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

Greece

ΒΙΑΝΕΞ Α.Ε.

Tel: +30 210 8009111 – 120

Austria

Astro-Pharma GmbH

Tel: +43 1 97 99 860

[email protected]

Spain

OMFE SA

Carretera Fuencarral-Alcobendas Nº 6 28049

Madrid

Tel: +34 917408700

[email protected]

Poland

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

France

CELLTRION HEALTHCARE FRANCE SAS

14 rue Cambacérès 75008 Paris

Tel: +33 (0)1 71 25 27 00

[email protected]

Portugal

PharmaKERN Portugal – Produtos Farmacêuticos, Sociedade Unipessoal, Lda.

Tel: +351 214 200 290

Croatia

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

Romania

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

Ireland

Celltrion Healthcare Ireland Ltd.

26, Arrow Building, Old Belgard Road, Tallaght,

Dublin D24 ND70, Ireland

Tel: +353-1-223-4026

Slovenia

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

Iceland

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

Slovakia

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

Italy

Celltrion Healthcare Italy S.R.L.

Tel: +39 0247 927040

Finland

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

Cyprus

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

Sweden

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

Latvia

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

United Kingdom (Northern Ireland)

Celltrion Healthcare Hungary Kft.

1062 Budapest

Váci út 1-3. WestEnd Office Building B tower

Hungary

Tel: +36 1 231 0493

[email protected]

Date of the last revision of this leaflet: {MM/AAAA}.

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu.

The leaflet can be found in all languages of the European Union/European Economic Area on the European Medicines Agency website.

This leaflet is available electronically in all EU/EEA languages if you scan this code.

Square QR code of black and white modules on a white background for access to additional information

URL: http://www.regkirona-eu.com

--------------------------------------------------------------------------------------------------------------------This information is intended only for healthcare professionals.

Consult the Summary of Product Characteristics or Package Leaflet for more information.

Instructions for healthcare professionals

Regkirona 60 mg/ml concentrate for solution for infusion

regdanvimab

Each single-use vial contains 960 mg of regdanvimab in 16 ml.

Regdanvimab should only be administered in environments where healthcare professionals have immediate access to appropriate resuscitation equipment and medications to treat a severe infusion reaction, including anaphylaxis.

Monitor the patient for potential adverse effects during infusion and for at least 1 hour after the end of the infusion.

If signs and symptoms of a hypersensitivity reaction or anaphylaxis with clinical relevance appear, discontinue treatment immediately and start administering the necessary medications and/or supportive treatment.

Dilution of the concentrate with sodium chloride solution for infusion

A qualified healthcare professional will prepare Regkirona solution for infusion using aseptic techniques:

  • Remove the Regkirona vials from the refrigerator and let them stand at room temperature (not exceeding 30 °C) for approximately 20 minutes before preparation. Do not expose to direct heat sources. Do not shake the vials.
  • Regkirona is a transparent to opalescent solution, colorless to pale yellow. Visually inspect the Regkirona vials for particles and color changes before dilution. If any are observed, discard the vials and use new vials for preparation.
  • Calculate the total administration volume of Regkirona. The volume of Regkirona is calculated as follows.

Calculation to determine the total administration volume of Regkirona:

Patient weight (kg) × Regkirona dose (40 mg/kg)

= Regkirona volume (ml)

Vial concentration (60 mg/ml)

Calculation to determine the total number of Regkirona vials needed:

Total administration volume of Regkirona (ml)

= Number of Regkirona vials

Total volume per vial (16 ml/vial)

needed

Table 1:Sample calculations for patients treated with the recommended dose of 40 mg/kg of Regkirona for a weight range of 40 to 120 kg

Weight (kg)

Total dose (mg)

Volume (ml)

Vials (n)

40

1,600

27

2

60

2,400

40

3

80

3,200

53

4

100

4,000

67

5

120

4,800

80

5

Note: If the patient's weight is above 200 kg, 200 kg should be used to calculate the dose. The maximum recommended dose is 8,000 mg.

  • Dilute Regkirona in a bag with sodium chloride 9 mg/ml (0.9%) solution for infusion. The total volume of the medication and sodium chloride should be 250 ml.
  • In a 250 ml bag with sodium chloride, withdraw and discard the necessary volume (equivalent to the calculated volume of Regkirona) of sodium chloride 9 mg/ml (0.9%) from the infusion bag.
  • Withdraw the calculated volume of Regkirona from the vials with a sterile syringe.
  • Transfer Regkirona to the infusion bag.
  • Gently invert the intravenous infusion bag with your hand approximately 10 times to mix. Do not shake.
  • This product does not contain preservatives, so the diluted infusion solution should be administered immediately. After aseptic dilution in a sodium chloride 9 mg/ml (0.9%) solution for infusion, the prepared Regkirona infusion solution in sodium chloride 9 mg/ml (0.9%) solution for infusion is physically and chemically stable for 72 hours at 2-8 °C or for 4 hours at ≤ 30 °C.
  • From a microbiological point of view, the prepared infusion solution should be used immediately. If not used immediately, the in-use storage times and conditions are the responsibility of the user and normally should not exceed 24 hours at 2-8 °C, unless the dilution has taken place in controlled and validated aseptic conditions. If refrigerated, let the infusion solution stand at room temperature (not exceeding 30 °C) for approximately 20 minutes before administration.

Administration of the infusion

Regkirona solution for infusion will be administered by a qualified healthcare professional.

  • Gather the recommended materials for infusion: intravenous infusion equipment with an in-line filter (a PES [polyethersulfone] filter with a pore size of 1.2 μm or less is recommended). Connect the infusion equipment to the intravenous infusion bag.
  • Connect the infusion equipment to the intravenous infusion bag.
  • Prime the infusion equipment.
  • Administer the intravenous infusion with an infusion pump over 60 minutes.
  • The prepared infusion solution should not be administered simultaneously with another medication.

The disposal of unused medicinal products and all materials that have come into contact with them should be carried out in accordance with local regulations.

Online doctors for REGKIRONA 60 mg/mL concentrate for infusion solution

Discuss dosage, side effects, interactions, contraindications, and prescription renewal for REGKIRONA 60 mg/mL concentrate for infusion solution – subject to medical assessment and local rules.

5.0(3)
Doctor

Ngozi Precious Okwuosa

General medicine6 years of experience

Dr. Ngozi Precious Okwuosa is a Primary Care Physician with over 5 years of clinical experience in Hungary, Sweden, and Nigeria. A graduate of the University of Szeged (cum laude), she offers online consultations for adults in the areas of internal medicine, women’s health, and postoperative care.

Key areas of consultation:

  • Preventive and family medicine
  • Women’s health, including gynaecology and obstetrics
  • Chronic disease management: hypertension, diabetes, and more
  • Mental health support, anxiety, and counselling
  • Postoperative care and lab test interpretation
She has conducted research on the genetic background of stroke and is skilled in communicating with patients from diverse cultural backgrounds. Her approach combines clinical expertise with empathy and clear communication.
CameraBook a video appointment
€50
January 705:45
January 706:35
January 707:25
January 708:15
January 709:05
More times
5.0(4)
Doctor

Salome Akhvlediani

Pediatrics12 years of experience

Dr Salome Akhvlediani is a paediatrician providing online consultations for children of all ages. She supports families with preventive care, diagnosis, and long-term management of both acute and chronic conditions.

Her areas of focus include:

  • Fever, infections, cough, sore throat, and digestive issues.
  • Preventive care – vaccinations, regular check-ups, and health monitoring.
  • Allergies, asthma, and skin conditions.
  • Nutritional advice and healthy development support.
  • Sleep difficulties, fatigue, and behavioural concerns.
  • Ongoing care for chronic or complex health conditions.
  • Guidance for parents and follow-up after medical treatment.

Dr Akhvlediani combines professional care with a warm, attentive approach – helping children stay healthy and supporting parents at every stage of their child’s growth.

CameraBook a video appointment
€45
January 706:00
January 706:40
January 707:20
January 708:00
January 708:40
More times
0.0(2)
Doctor

Muhammad Tayyab Altaf

General medicine3 years of experience

Dr. Muhammad Tayyab Altaf is a primary care physician with extensive international experience, offering online consultations for adults and children. His background includes clinical practice in Policlinico San Matteo Hospital Pavia in Italy, Mount Sinai Hospital in New York, United States and other healthcare settings, allowing him to manage a wide range of acute and chronic medical conditions with confidence and clarity.

His clinical expertise spans multi-system conditions, preventive care and long-term management of chronic diseases. Dr. Altaf combines hands-on experience with a strong research background in both medical and surgical fields, enabling him to provide accurate assessments and structured, evidence-based treatment plans. Patients value his ability to explain diagnoses clearly, outline next steps and support them in making informed healthcare decisions.

Online consultations with Dr. Altaf are suitable for many everyday and acute situations where a timely medical opinion can help determine the safest next steps. He evaluates and treats conditions affecting the cardiovascular, respiratory, gastrointestinal, neurological, haematological and endocrine systems. Common examples include:

  • hypertension and other blood pressure issues
  • ischaemic heart disease and angina
  • asthma, COPD and emphysema
  • pneumonia and lung fibrosis
  • gastroenteritis and digestive infections
  • liver conditions, including alcohol-related disease
  • epilepsy, seizures and post-stroke symptoms
  • dementia and cognitive decline
  • anaemia and other haematological changes
  • diabetes, thyroid disorders and pituitary disease
Many patients reach out when they experience new or worsening symptoms, fluctuations in blood pressure, non-severe chest discomfort, breathing symptoms, digestive issues, suspected infections, chronic fatigue or concerns that affect daily life. He also helps patients understand test results, adjust existing treatment plans and navigate long-term health strategies safely and effectively.

When clinically appropriate, Dr. Altaf can also provide health and fitness certificates, including documentation required for physical activity, sports participation or gym use, based on the patient’s health status and medical indications.

Some conditions are not suitable for online care. Severe chest pain, loss of consciousness, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack require immediate attention from local emergency services. Dr. Altaf prioritises patient safety and will guide you accordingly if your situation needs urgent in-person care.

In all consultations, Dr. Muhammad Tayyab Altaf focuses on clear communication, accurate diagnosis and patient-centred decision-making. His approach ensures that individuals and families feel informed, supported and confident in their next steps, no matter where they are.

CameraBook a video appointment
€65
January 706:00
January 706:45
January 707:30
January 708:15
January 709:00
More times
0.0(5)
Doctor

Karina Travkina

Otolaryngology (ENT)17 years of experience

Dr Karina Travkina is an ENT specialist providing online consultations for adults with acute and chronic conditions affecting the ears, nose and throat. She takes a structured and personalised approach to each consultation, beginning with a thorough review of symptoms and medical history, followed by diagnostic interpretation and a tailored treatment plan.

Common reasons for consultation include:

  • chronic pharyngitis and recurrent tonsillitis
  • allergic, vasomotor and medication-induced rhinitis
  • sinusitis, nasal obstruction, and postnasal drip
  • nosebleeds, earwax build-up, or foreign bodies in the ear, nose, or throat
  • Eustachian tube dysfunction and related complaints
Dr Travkina follows evidence-based guidelines and ensures patients receive clear explanations and follow-up recommendations. Whether you need help with ENT symptoms, clarification of test results, or guidance on next steps – she offers expert medical advice in a convenient online format.
CameraBook a video appointment
€64
January 706:30
January 707:00
January 707:30
January 708:00
January 708:30
More times
5.0(14)
Doctor

Tarek Agami

General medicine11 years of experience

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

CameraBook a video appointment
€69
January 707:00
January 707:25
January 707:50
January 708:15
January 708:40
More times
0.0(0)
Doctor

Daniel Cichi

Family medicine24 years of experience

Dr Daniel Cichi is a family medicine doctor with over 20 years of clinical experience. He provides online consultations for adults, supporting patients with acute symptoms, chronic conditions, and everyday health concerns that require timely medical guidance.

His background includes work in emergency care, ambulance services, and family medicine, which allows him to assess symptoms quickly, identify warning signs, and help patients choose the safest next steps – whether that means home care, treatment adjustment, or in-person evaluation.

Patients commonly consult Dr Daniel Cichi for:

  • acute symptoms: fever, infections, flu-like illness, cough, sore throat, shortness of breath;
  • chest discomfort, palpitations, dizziness, fatigue, and blood pressure concerns;
  • digestive problems: abdominal pain, nausea, diarrhoea, constipation, reflux;
  • muscle, joint, and back pain, minor injuries, post-traumatic symptoms;
  • chronic conditions: hypertension, diabetes, high cholesterol, thyroid disorders;
  • review and interpretation of lab tests, imaging reports, and medical documents;
  • medication review and treatment adjustment;
  • medical advice while travelling or living abroad;
  • second opinions and guidance on whether in-person care is needed.
Dr Cichi’s consultations are structured and practical. He focuses on clear explanations, risk assessment, and actionable recommendations, helping patients understand their symptoms and make informed decisions about their health.
CameraBook a video appointment
€55
January 707:00
January 707:45
January 708:30
January 709:15
January 710:00
More times
0.0(0)
Doctor

Andreea Mateescu

Pediatrics8 years of experience

Dr Andreea Mateescu is a board-certified paediatrician with 7 years of clinical experience. She graduated from Carol Davila University of Medicine and Pharmacy in Bucharest, Romania, and completed her paediatric residency at INSMC Alessandrescu-Rusescu. She also holds additional training in general ultrasound diagnostics.

Dr Mateescu focuses on providing high-quality, evidence-based medical care for children, with a strong emphasis on prevention, healthy development, and long-term wellbeing. She believes that clear, empathetic communication with both children and parents is essential for building trust and ensuring effective care.

Online consultations with Dr Mateescu are suitable for:

  • preventive check-ups and monitoring of growth and development;
  • vaccination planning, including personalised and catch-up schedules;
  • assessment of psychomotor, emotional, and physical development;
  • diagnosis and management of acute and chronic paediatric conditions;
  • nutritional guidance for infants and children, including formula selection when medically indicated;
  • care for children with complex or rare conditions;
  • practical guidance and ongoing support for parents.
Dr Mateescu works with patience, empathy, and professionalism, ensuring that each child receives attentive, individualised care. Her goal is to support healthy, balanced development while helping parents feel confident and well-informed at every stage of their child’s care.
CameraBook a video appointment
€60
January 707:30
January 707:55
January 708:20
January 708:45
January 709:10
More times
5.0(52)
Doctor

Nuno Tavares Lopes

Family medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

CameraBook a video appointment
€59
January 708:00
January 708:20
January 708:40
January 709:00
January 709:20
More times
5.0(32)
Doctor

Sergio Correa

General medicine8 years of experience

Dr. Sergio Correa is a licensed general practitioner, aesthetic medicine specialist, and trichologist with experience in emergency care and preventive health. He offers online consultations in English and Spanish, supporting adult patients with a wide range of medical concerns – from acute symptoms to chronic condition management.

His areas of focus include:

  • General and urgent care: fever, fatigue, infections, digestive issues, respiratory symptoms, and other common concerns
  • Chronic condition support: hypertension, high cholesterol, diabetes, thyroid issues
  • Aesthetic medicine and dermatology: acne, skin ageing, hyperpigmentation, personalised skincare guidance
  • Trichology: hair loss, scalp conditions, treatment strategies for men and women
  • Preventive care: health check-ups, lifestyle advice, second opinions

Dr. Correa combines medical knowledge with an aesthetic and holistic approach to help patients improve both health and quality of life.

CameraBook a video appointment
€39.5
January 708:00
January 709:00
January 710:00
January 711:00
January 712:00
More times
0.0(0)
Doctor

Tetiana Fedoryshyn

General medicine30 years of experience

Dr Tetiana Fedoryshyn is a senior general practitioner, certified nutritionist, and psychologist with over 29 years of clinical experience. She combines classical internal medicine with modern approaches in lifestyle medicine, functional nutrition, and emotional health support.

Her focus is on helping patients regain health through deep understanding of symptoms, personalised nutrition plans, and evidence-based correction of deficiencies, stress-related conditions, and metabolic imbalances. Dr Fedoryshyn works with adults experiencing chronic conditions, fatigue, hormonal disruption, and post-stress exhaustion.

She integrates medical analysis, psychological insight, and real-life behaviour change tools to offer treatment plans tailored to each patient’s biochemistry, mental state, and lifestyle.

Main areas of practice:

  • Chronic condition management and medical counselling
  • Weight loss programmes based on metabolic profiling
  • Diagnosis and treatment of micronutrient deficiencies
  • Recovery from stress, burnout, and hormonal imbalances
  • Emotional support and psychosomatic symptom care
Her approach is never one-size-fits-all – each consultation begins with a deep dive into your unique health history, test results, and emotional landscape. Consultations are available in Ukrainian, Polish, and Russian.
CameraBook a video appointment
€65
January 708:00
January 708:25
January 708:50
January 709:15
January 709:40
More times

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2026 Oladoctor. All rights reserved.
VisaMastercardStripe